JP2010222379A5 - - Google Patents

Download PDF

Info

Publication number
JP2010222379A5
JP2010222379A5 JP2010150627A JP2010150627A JP2010222379A5 JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5 JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5
Authority
JP
Japan
Prior art keywords
seq
residues
fetoprotein
acid sequence
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010150627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010222379A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010222379A publication Critical patent/JP2010222379A/ja
Publication of JP2010222379A5 publication Critical patent/JP2010222379A5/ja
Pending legal-status Critical Current

Links

JP2010150627A 1997-02-13 2010-06-30 肝細胞癌の予防又は処置のための組成物 Pending JP2010222379A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3837597P 1997-02-13 1997-02-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006038626A Division JP2006188528A (ja) 1997-02-13 2006-02-15 肝細胞癌の予防又は処置のための組成物

Publications (2)

Publication Number Publication Date
JP2010222379A JP2010222379A (ja) 2010-10-07
JP2010222379A5 true JP2010222379A5 (https=) 2010-11-18

Family

ID=21899585

Family Applications (3)

Application Number Title Priority Date Filing Date
JP53591698A Expired - Lifetime JP3816959B2 (ja) 1997-02-13 1998-02-13 肝細胞癌の予防および処置
JP2006038626A Withdrawn JP2006188528A (ja) 1997-02-13 2006-02-15 肝細胞癌の予防又は処置のための組成物
JP2010150627A Pending JP2010222379A (ja) 1997-02-13 2010-06-30 肝細胞癌の予防又は処置のための組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP53591698A Expired - Lifetime JP3816959B2 (ja) 1997-02-13 1998-02-13 肝細胞癌の予防および処置
JP2006038626A Withdrawn JP2006188528A (ja) 1997-02-13 2006-02-15 肝細胞癌の予防又は処置のための組成物

Country Status (8)

Country Link
US (1) US20020031520A1 (https=)
EP (1) EP0979239B1 (https=)
JP (3) JP3816959B2 (https=)
KR (1) KR100460583B1 (https=)
CN (2) CN1222536C (https=)
AU (1) AU6435398A (https=)
DE (1) DE69836209D1 (https=)
WO (1) WO1998035981A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1255427C (zh) * 2000-02-10 2006-05-10 加利福尼亚州大学董事会 用于治疗肝细胞癌的方法和组合物
FI118263B (fi) 2002-10-09 2007-09-14 Timo Kalevi Korpela Kaspaasiaktiivisuutta säätelevät peptidit
US8932829B2 (en) 2005-07-07 2015-01-13 Elena Dudich Recombinant alpha-fetoprotein and compositions thereof
GB0617564D0 (en) * 2006-09-06 2006-10-18 Ucl Business Plc Peptides and methods
KR100900742B1 (ko) * 2007-05-17 2009-06-08 크레아젠 주식회사 인간 간암 동물모델 및 이를 이용한 수지상세포-유래 간암면역치료제의 예방 및 치료 효능을 분석하는 방법
AU2010309438A1 (en) * 2009-10-22 2012-06-07 Ricardo J. Moro Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
EP3640375A3 (en) 2012-12-11 2020-07-29 Albert Einstein College of Medicine Methods for high throughput receptor/ligand identification
AU2016243026B2 (en) 2015-04-03 2022-03-31 Eureka Therapeutics, Inc. Constructs targeting AFP peptide/MHC complexes and uses thereof
CN105126074A (zh) * 2015-09-30 2015-12-09 中国药科大学 多肽afp12在制备抗肿瘤药物中的应用
CN105524884A (zh) * 2016-02-29 2016-04-27 时宏珍 Hla-a0201限制性抗afp抗原特异性ctl的制备方法
KR20190044029A (ko) 2016-05-18 2019-04-29 알버트 아인슈타인 컬리지 오브 메디슨, 인크. 변이체 pd-l1 폴리펩타이드, t-세포 조절 다량체 폴리펩타이드 및 이들의 사용 방법
CA3019005A1 (en) 2016-05-18 2017-11-23 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
CN116970059A (zh) 2016-12-22 2023-10-31 库尔生物制药有限公司 T细胞调节性多聚体多肽及其使用方法
US11851471B2 (en) 2017-01-09 2023-12-26 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
IL269000B2 (en) 2017-03-15 2024-06-01 Cue Biopharma Inc Methods for modulating an immune response
WO2019139896A1 (en) 2018-01-09 2019-07-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
TW202208395A (zh) 2020-05-12 2022-03-01 美商信號生物製藥公司 多聚體t細胞調節多肽及其使用方法
EP4211149A4 (en) 2020-09-09 2024-10-09 Cue Biopharma, Inc. MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
CN113416729B (zh) * 2021-05-18 2022-11-22 遵义医科大学附属医院 一种肝脏靶向调控甲胎蛋白基因的shRNA和cDNA及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH025866A (ja) * 1988-06-27 1990-01-10 Kansai Shin Gijutsu Kenkyusho:Kk ヒトアルファフェトプロテインドメインi遺伝子、対応プラスミド組換体、対応形質転換体、該ドメインiの製造法及び製造された該ドメインi
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US5633234A (en) * 1993-01-22 1997-05-27 The Johns Hopkins University Lysosomal targeting of immunogens
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
JPH10513347A (ja) * 1995-01-24 1998-12-22 ロバート エイ. マルギタ 組換え型ヒトα−フェトプロテインおよびその利用

Similar Documents

Publication Publication Date Title
JP2010222379A5 (https=)
ES2545895T3 (es) Proteína de fusión anticancerígena
JP2015525217A5 (https=)
NZ593833A (en) Extended recombinant polypeptides and compositions comprising same
JP2013513377A5 (https=)
EP3919507A3 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
JP2024041747A5 (https=)
JP2009268467A5 (https=)
EP3712165A3 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
RU2021134101A (ru) Модифицированная j-цепь
JP2014224126A5 (https=)
JP2015134796A5 (https=)
MX2020010806A (es) Peptidos anti-inflamatorios y usos de los mismos.
CY1116099T1 (el) Πρωτεϊνη συντηξης κατα του καρκινου
MX2021000030A (es) Metodos y composiciones que utilizan polipeptidos variantes klotho.
NZ707439A (en) Modified factor ix polypeptides and uses thereof
JP2015514395A5 (https=)
NZ705899A (en) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
NZ726623A (en) Improved peptide pharmaceuticals for insulin resistance
JP2007529204A5 (https=)
EP2589658A4 (en) PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
FI3737399T3 (fi) ATF5-peptidivariantit ja niiden käytöt
JP2014047156A5 (https=)
JP2013517764A5 (https=)